(Q48944762)

17 February 2018

title

The cannabinergic system is implicated in the upregulation of central NGF protein by psychotropic drugs. (English)

1 reference

17 February 2018

author name string

Parichehr Hassanzadeh

series ordinal

1

1 reference

17 February 2018

Sina Rahimpour

series ordinal

2

1 reference

17 February 2018

publication date

18 December 2010

1 reference

17 February 2018

number of pages

13

1 reference

inferred from page(s)

published in

Psychopharmacology

1 reference

17 February 2018

volume

215

1 reference

17 February 2018

issue

1

1 reference

17 February 2018

page(s)

129-141

1 reference

17 February 2018

https://scigraph.springernature.com/pub.10.1007/s00213-010-2120-4

exact match

0 references

cites work

Selective loss of brain-derived neurotrophic factor in the dentate gyrus attenuates antidepressant efficacy

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

NGF regulatory role in stress and coping of rodents and humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Protracted effects of chronic oral haloperidol and risperidone on nerve growth factor, cholinergic neurons, and spatial reference learning in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Chronic antipsychotic treatment selectively alters nerve growth factor and neuropeptide Y immunoreactivity and the distribution of choline acetyl transferase in rat brain regions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Reduced serum concentrations of nerve growth factor, but not brain-derived neurotrophic factor, in chronic cannabis abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

BDNF impairment in the hippocampus is related to enhanced despair behavior in CB1 knockout mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Endocannabinoids in the treatment of mood disorders: evidence from animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Chronic unpredictable stress decreases cell proliferation in the cerebral cortex of the adult rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Some effects of CB1 antagonists with inverse agonist and neutral biochemical properties

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Brain regional distribution of endocannabinoids: implications for their biosynthesis and biological function.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Selective antibody-induced cholinergic cell and synapse loss produce sustained hippocampal and cortical hypometabolism with correlated cognitive deficits

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A neutral CB1 receptor antagonist reduces weight gain in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Rimonabant, a cannabinoid CB1 receptor antagonist, attenuates mechanical allodynia and counteracts oxidative stress and nerve growth factor deficit in diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

NGF is essential for hippocampal plasticity and learning

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Effect of repeated systemic administration of selective inhibitors of endocannabinoid inactivation on rat brain endocannabinoid levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential regulation of brain derived neurotrophic factor transcripts by antidepressant treatments in the adult rat brain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Function and evolution in the NGF family and its receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Chronic exposure of sensory neurones to increased levels of nerve growth factor modulates CB1/TRPV1 receptor crosstalk

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Isolation and measurement of the endogenous cannabinoid receptor agonist, anandamide, in brain and peripheral tissues of human and rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Changes in endocannabinoid contents in the brain of rats chronically exposed to nicotine, ethanol or cocaine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Mechanisms of action of the antidepressants fluoxetine and the substance P antagonist L-000760735 are associated with altered neurofilaments and synaptic remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Time-dependent increase in basic fibroblast growth factor protein in limbic regions following electroshock seizures.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Serotonergic lesion of median raphe nucleus alters nerve growth factor content and vulnerability of cholinergic septohippocampal neurons in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Subchronic treatment with lithium increases nerve growth factor content in distinct brain regions of adult rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Involvement of the endocannabinoid system in the ability of long-term tricyclic antidepressant treatment to suppress stress-induced activation of the hypothalamic-pituitary-adrenal axis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential effects of the antidepressants tranylcypromine and fluoxetine on limbic cannabinoid receptor binding and endocannabinoid contents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Regional alterations in the endocannabinoid system in an animal model of depression: effects of concurrent antidepressant treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Augmentation by citalopram of risperidone-induced monoamine release in rat prefrontal cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Nerve Growth Factor: Structure, Function and Therapeutic Implications for Alzheimers Disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Increasing hippocampal neurogenesis: a novel mechanism for antidepressant drugs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Enhancement of endocannabinoid signaling and the pharmacotherapy of depression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Physiology and neurobiology of stress and adaptation: central role of the brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The effects of clozapine, risperidone, and olanzapine on cognitive function in schizophrenia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Current trends in the development of new antidepressants

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

An endogenous cannabinoid (2-AG) is neuroprotective after brain injury

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Nerve growth factor in never-medicated first-episode psychotic and medicated chronic schizophrenic patients: possible implications for treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential regulation of the endocannabinoids anandamide and 2-arachidonylglycerol within the limbic forebrain by dopamine receptor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The postmortal accumulation of brain N-arachidonylethanolamine (anandamide) is dependent upon fatty acid amide hydrolase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential effects of long-term treatment with typical and atypical antipsychotics on NGF and BDNF levels in rat striatum and hippocampus

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Altered CB receptor-signaling in prefrontal cortex from an animal model of depression is reversed by chronic fluoxetine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The role of neurotrophic factors in adult hippocampal neurogenesis, antidepressant treatments and animal models of depressive-like behavior

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Social cognition [corrected] and neurocognition: effects of risperidone, olanzapine, and haloperidol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A possible role for the endocannabinoid system in the neurobiology of depression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The novel cannabinoid CB1 receptor neutral antagonist AM4113 suppresses food intake and food-reinforced behavior but does not induce signs of nausea in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

A randomized, double-blind comparison of olanzapine/fluoxetine combination, olanzapine, and fluoxetine in treatment-resistant major depressive disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Differential effects of typical and atypical antipsychotics on nerve growth factor and choline acetyltransferase expression in the cortex and nucleus basalis of rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Endocannabinoid system and stress and anxiety responses.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

The FGF receptor uses the endocannabinoid signaling system to couple to an axonal growth response

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Risperidone attenuates brain damage after focal cerebral ischemia in vivo.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Cannabinoids produce neuroprotection by reducing intracellular calcium release from ryanodine-sensitive stores.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00213-010-2120-4

Endocannabinoid system and synaptic plasticity: implications for emotional responses

21 January 2018

1 reference

12 December 2020

Use of atypical antipsychotics in refractory depression and anxiety.

1 reference

12 December 2020

Neuromodulatory functions of the endocannabinoid system

1 reference

12 December 2020

Liquid chromatographic-atmospheric pressure chemical ionization mass spectrometric determination of anandamide and its analogs in rat brain and peripheral tissues

1 reference

12 December 2020

Nerve growth factor (NGF) augments cortical and hippocampal cholinergic functioning after p75NGF receptor-mediated deafferentation but impairs inhibitory avoidance and induces fear-related behaviors.

1 reference

12 December 2020

Nerve growth factor (NGF) content in adult rat brain tissues is several-fold higher than generally reported and is largely associated with sedimentable fractions

1 reference

12 December 2020

10.1007/S00213-010-2120-4

Identifiers

DOI

1 reference

17 February 2018

1 reference

17 February 2018